Sign inJoin waitlistJoin the waitlist

DT

David Taber

Hematology & Oncology

Credentials: ·

History

Hematology and Medical Oncology
1983–1986
Internal Medicine
1980–1983
Medical School
1976–1980

Research

Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer
Journal of Clinical Oncology · 2005 · 389 citations
Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study
Journal of Clinical Oncology · 2000 · 177 citations
Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma
Journal of Clinical Oncology · 2012 · 143 citations

Everett Vokes
10 papers
Walter Stadler
7 papers
Hedy Kindler
5 papers
NV
Nicholas Vogelzang
5 papers
RA
Rafat Ansari
4 papers
AM
Ann Mauer
2 papers
CR
Christopher Ryan
2 papers
DS
Deepti Singh
2 papers
JW
James Wade
2 papers
JM
John McClean
2 papers
MK
Mark Kozloff
2 papers
Mark Ratain
2 papers